MedPath

UNIVERSITY HOSPITALS CLEVELAND MEDICAL CENTER

UNIVERSITY HOSPITALS CLEVELAND MEDICAL CENTER logo
🇺🇸United States
Ownership
Private
Employees
-
Market Cap
-
Website
http://www.uhhospitals.org

The Effect of Pollen Season on Subcutaneous Allergen Immunotherapy Reactions

Phase 1
Conditions
Allergic Rhinitis
Asthma
Allergic Conjunctivitis
Interventions
Drug: Allergen(Tree, Grass, Weeds)
First Posted Date
2013-06-17
Last Posted Date
2013-06-17
Lead Sponsor
University Hospitals Cleveland Medical Center
Target Recruit Count
245
Registration Number
NCT01878929
Locations
🇺🇸

Allergy/Immunology Associates Inc., South Euclid, Ohio, United States

Cerebral Oximetry in Single Lung Ventilation Thoracic Surgery

Not Applicable
Terminated
Conditions
Hypoxia
Interventions
Drug: Vasoconstrictor Agents
Other: Head/neck repositioning
Other: Increase ETCO2
Other: IV fluid bolus
Drug: Additional anesthesia
Biological: RBC transfusion
Drug: Increase FiO2
First Posted Date
2013-05-31
Last Posted Date
2022-07-05
Lead Sponsor
University Hospitals Cleveland Medical Center
Target Recruit Count
74
Registration Number
NCT01866657
Locations
🇺🇸

University Hospitals Case Medical Center, Cleveland, Ohio, United States

Use of Dexmedetomidine in Acute Stroke and Cerebral Vasospasm Interventions

Phase 2
Terminated
Conditions
Brain Ischemia
Stroke
Vasospasm, Intracranial
Hemorrhage, Intracranial
Interventions
First Posted Date
2013-05-03
Last Posted Date
2022-12-28
Lead Sponsor
University Hospitals Cleveland Medical Center
Target Recruit Count
7
Registration Number
NCT01845441
Locations
🇺🇸

University Hospitals of Cleveland, Cleveland, Ohio, United States

Infant Antibiotic Resistance and Implications for Therapeutic Decision-making

Completed
Conditions
Bacterial Infections and Mycoses
First Posted Date
2013-01-31
Last Posted Date
2017-05-03
Lead Sponsor
University Hospitals Cleveland Medical Center
Target Recruit Count
352
Registration Number
NCT01781182
Locations
🇺🇸

University Hospitals Case Medical Center, Cleveland, Ohio, United States

Systematic Genetic Analysis of Phenomenology and Treatment Response in Mood Disorders

Terminated
Conditions
Bipolar Disorder
Major Depressive Disorder
First Posted Date
2013-01-17
Last Posted Date
2023-06-29
Lead Sponsor
University Hospitals Cleveland Medical Center
Target Recruit Count
396
Registration Number
NCT01769859

Evaluation of a Novel Endoscopic Treatment for Achalasia

Not Applicable
Completed
Conditions
Achalasia
Interventions
Procedure: Per-oral Endoscopic Esophagomyotomy (POEM)
First Posted Date
2013-01-17
Last Posted Date
2022-04-20
Lead Sponsor
University Hospitals Cleveland Medical Center
Target Recruit Count
10
Registration Number
NCT01770249
Locations
🇺🇸

University Hospitals Case Medical Center, Cleveland, Ohio, United States

Optical Imaging Measurement of Intravascular Solution Efficacy Trial

Not Applicable
Completed
Conditions
Peripheral Artery Disease
Interventions
Procedure: Contrast Injection
Procedure: Dextran Injection
Procedure: CO2 Injection
Procedure: Heparinized Normal Saline Injection
First Posted Date
2012-12-06
Last Posted Date
2022-09-21
Lead Sponsor
University Hospitals Cleveland Medical Center
Target Recruit Count
23
Registration Number
NCT01743872
Locations
🇺🇸

University Hospitals Case Medical Center, Cleveland, Ohio, United States

QI Study of a Practice Facilitator's Impact in Working With Clinics on Improving Dental, Lead & Obesity Measures for Children

Not Applicable
Completed
Conditions
Lead Poisoning
Dental Decay
Obesity
Interventions
Other: Practice-tailored intervention to increase rates of targeted services
First Posted Date
2012-12-03
Last Posted Date
2014-12-03
Lead Sponsor
University Hospitals Cleveland Medical Center
Target Recruit Count
30
Registration Number
NCT01739166
Locations
🇺🇸

University Hospital Case Medical Center, Cleveland, Ohio, United States

Evaluation of a TAP Block Given During Laparoscopic Colorectal Surgery to Help Control Pain

Not Applicable
Completed
Conditions
Colorectal Disease
Interventions
Drug: normal saline placebo (for bupivacaine)
First Posted Date
2012-11-22
Last Posted Date
2022-11-03
Lead Sponsor
University Hospitals Cleveland Medical Center
Target Recruit Count
79
Registration Number
NCT01731782
Locations
🇺🇸

University Hospitals Case Medical Center, Cleveland, Ohio, United States

Pioglitazone for the Treatment of Bipolar Depression

Phase 4
Terminated
Conditions
Bipolar Disorder
Insulin Resistance
Interventions
Drug: Placebo
First Posted Date
2012-10-30
Last Posted Date
2017-01-27
Lead Sponsor
University Hospitals Cleveland Medical Center
Target Recruit Count
37
Registration Number
NCT01717040
Locations
🇺🇸

University Hospitals Cleveland Medical Center - Mood Disorders Program, Cleveland, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath